Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure

被引:195
作者
Dhainaut, JF
Shorr, AF
Macias, WL
Kollef, MJ
Levi, M
Reinhart, K
Nelson, DR
机构
[1] Univ Paris 05, Cochin Hosp, Cochin Inst, APHP,Cochin Port Royal Med Sch,Dept Intens Care, F-75679 Paris 14, France
[2] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[4] Barnes Jewish Hosp, Dept Crit Care Med, St Louis, MO 63110 USA
[5] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands
[6] Clin Anaesthesiol & Intens Care, Jena, Germany
关键词
sepsis; coagulation; prothrombin time; antithrombin; D-dimer; mortality; Sequential Organ Failure Assessment;
D O I
10.1097/01.CCM.0000153520.31562.48
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine whether changes in coagulation biomarkers during the first day of severe sepsis correlate with progression from single to multiple organ failure and subsequent death. Design: Analysis of secondary endpoints in a prospective, randomized, placebo-controlled, multinational clinical trial (PROWESS). Setting: The study involved 164 medical centers. Patients. A total of 840 patients who met criteria for severe sepsis and were randomized to receive placebo plus supportive care. Interventions. None. Measurements and Main Results. Coagulation biomarkers, prothrombin time, antithrombin activity, and D-dimer and protein C levels were measured, and Sequential Organ Failure Assessment was performed daily. Multiple logistic regression analysis identified baseline antithrombin activity < 54% and changes in prothrombin time, D-dimer, and antithrombin activity during the first calendar day after the onset of the first sepsis-induced organ dysfunction (i.e., the first day of severe sepsis, day 1) as predictive of 28-day mortality (p less than or equal to .01). A composite coagulopathy score was determined using points for predetermined levels of change from baseline to day 1. The composite coagulopathy score correlated with progression from single to multiple organ failure (p = .0007), time to resolution of organ failure (p = .0004), and 28-day mortality (p < .0001). Combining the composite coagulopathy score with the Acute Physiology and Chronic Health Evaluation (APACHE) II score improved ability to identify patients who would progress to multiple organ failure (area under receiver operating characteristic curve 0.61 APACHE II vs. 0.65 APACHE II + composite coagulopathy score) and who would die (area under receiver operating characteristic curve 0.69 APACHE II vs. 0.74 APACHE II + composite coagulopathy score). Conclusions. Continuation or worsening of coagulopathy during the first day of severe sepsis was associated with increased development of new organ failure and 28-day mortality. These results further suggest that coagulation abnormalities contribute to organ failure and death.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 32 条
  • [1] Anderson Robert N, 2002, Natl Vital Stat Rep, V50, P1
  • [2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [3] Depressed plasma activity of plasminogen or α2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation
    Asakura, H
    Ontachi, Y
    Mizutani, T
    Kato, M
    Ito, T
    Saito, M
    Morishita, E
    Yamazaki, M
    Suga, Y
    Miyamoto, KI
    Nakao, S
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (04) : 275 - 281
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: Data from the PROWESS trial
    Dhainaut, JF
    Laterre, PF
    Janes, JM
    Bernard, GR
    Artigas, A
    Bakker, J
    Riess, H
    Basson, BR
    Charpentier, J
    Utterback, BG
    Vincent, JL
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (06) : 894 - 903
  • [6] DHAINAUT JF, IN PRESS THROMB HAEM
  • [7] Serial evaluation of the SOFA score to predict outcome in critically ill patients
    Ferreira, FL
    Bota, DP
    Bross, A
    Mélot, C
    Vincent, JL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (14): : 1754 - 1758
  • [8] SEPTIC SHOCK, MULTIPLE ORGAN FAILURE, AND DISSEMINATED INTRAVASCULAR COAGULATION - COMPARED PATTERNS OF ANTITHROMBIN-III, PROTEIN-C, AND PROTEIN-S DEFICIENCIES
    FOURRIER, F
    CHOPIN, C
    GOUDEMAND, J
    HENDRYCX, S
    CARON, C
    RIME, A
    MAREY, A
    LESTAVEL, P
    [J]. CHEST, 1992, 101 (03) : 816 - 823
  • [9] Gando S, 1996, THROMB HAEMOSTASIS, V75, P224
  • [10] Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock
    Gando, S
    Nanzaki, S
    Sasaki, S
    Aoi, K
    Kemmotsu, O
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (12) : 2005 - 2009